Luciano Potena1, Andreas Zuckermann2, Francesco Barberini3, Arezu Aliabadi-Zuckermann2. 1. Heart Transplant Program, Bologna Academic Hospital, Policlinico S. Orsola-Malpighi, Building 25, Via Massarenti, 9, 40138, Bologna, Italy. luciano.potena2@unibo.it. 2. Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria. 3. Heart Transplant Program, Bologna Academic Hospital, Policlinico S. Orsola-Malpighi, Building 25, Via Massarenti, 9, 40138, Bologna, Italy.
Abstract
PURPOSE OF REVIEW: Despite the improvement in medical therapy for heart failure and the advancements in mechanical circulatory support, heart transplantation (HT) still remains the best therapeutic option to improve survival and quality of life in patients with advanced heart failure. Nevertheless, HT recipients are exposed to the risk of several potential complications that may impair their outcomes. In this article, we aim to provide a practical and scholarly framework for clinicians approaching heart transplant medicine, as well as a concise update for the experienced readers on the most relevant post-HT complications. RECENT FINDINGS: While recognizing that most of the treatments herein discussed are based more on experience than on solid scientific evidence, significant step forward has been made in particular in the recognition and management of primary graft dysfunction, antibody-mediated rejection, and renal dysfunction. Complications after HT may vary according to the time from surgery and can be related to graft function and pathology or to diseases and dysfunctions occurring in other organs or systems, mainly as side effects of immunosuppressive drugs and progression of pre-existing conditions. Future research needs to focus on improving precision diagnostics of causes of graft dysfunction and on reaching an optimal and customized balance between efficacy and toxicities of immunosuppressive strategies.
PURPOSE OF REVIEW: Despite the improvement in medical therapy for heart failure and the advancements in mechanical circulatory support, heart transplantation (HT) still remains the best therapeutic option to improve survival and quality of life in patients with advanced heart failure. Nevertheless, HT recipients are exposed to the risk of several potential complications that may impair their outcomes. In this article, we aim to provide a practical and scholarly framework for clinicians approaching heart transplant medicine, as well as a concise update for the experienced readers on the most relevant post-HT complications. RECENT FINDINGS: While recognizing that most of the treatments herein discussed are based more on experience than on solid scientific evidence, significant step forward has been made in particular in the recognition and management of primary graft dysfunction, antibody-mediated rejection, and renal dysfunction. Complications after HT may vary according to the time from surgery and can be related to graft function and pathology or to diseases and dysfunctions occurring in other organs or systems, mainly as side effects of immunosuppressive drugs and progression of pre-existing conditions. Future research needs to focus on improving precision diagnostics of causes of graft dysfunction and on reaching an optimal and customized balance between efficacy and toxicities of immunosuppressive strategies.
Authors: Lars Gullestad; Svend-Aage Mortensen; Hans Eiskjær; Gerdt C Riise; Lena Mared; Oystein Bjørtuft; Björn Ekmehag; Kjell Jansson; Svein Simonsen; Einar Gude; Bengt Rundqvist; Hans E Fagertun; Dag Solbu; Martin Iversen Journal: Transplantation Date: 2010-12-27 Impact factor: 4.939
Authors: Koji Takeda; Boyangzi Li; Arthur R Garan; Veli K Topkara; Jiho Han; Paolo C Colombo; Maryjane A Farr; Yoshifumi Naka; Hiroo Takayama Journal: J Heart Lung Transplant Date: 2016-12-23 Impact factor: 10.247
Authors: Susan Stewart; Gayle L Winters; Michael C Fishbein; Henry D Tazelaar; Jon Kobashigawa; Jacki Abrams; Claus B Andersen; Annalisa Angelini; Gerald J Berry; Margaret M Burke; Anthony J Demetris; Elizabeth Hammond; Silviu Itescu; Charles C Marboe; Bruce McManus; Elaine F Reed; Nancy L Reinsmoen; E Rene Rodriguez; Alan G Rose; Marlene Rose; Nicole Suciu-Focia; Adriana Zeevi; Margaret E Billingham Journal: J Heart Lung Transplant Date: 2005-06-20 Impact factor: 10.247
Authors: P Bruneval; A Angelini; D Miller; L Potena; A Loupy; A Zeevi; E F Reed; D Dragun; N Reinsmoen; R N Smith; L West; S Tebutt; T Thum; M Haas; M Mengel; P Revelo; M Fedrigo; J P Duong Van Huyen; G J Berry Journal: Am J Transplant Date: 2016-12-12 Impact factor: 8.086
Authors: Olga Shevchenko; Olga Tsirulnikova; Sofya Sharapchenko; Olga Gichkun; Dmitriy Velikiy; Nina Gabrielyan; Ivan Pashkov; Alex Shevchenko; Sergey Gautier Journal: Noncoding RNA Res Date: 2022-08-31